Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Veracyte Inc (Veracyte) is a molecular diagnostics company that specializes in genomic testing for cancer diagnosis and treatment. The company’s products include Afirma genomic sequencing classifier for thyroid cancer, Decipher prostate genomic classifier targets prostate cancer; the prosigna breast cancer assay, which treats breast cancer; Decipher bladder genomic classifier targets bladder cancer; Percepta nasal swab test treats lung cancer; and Lymphmark targets diffuse large B-cell lymphoma. Its MRD technology platform delivers high-performing cancer tests by broad genomic and clinical data, deep bioinformatic and AI capabilities, and a powerful evidence-generation engine. The company operates in the US, the Netherlands, France and Israel. Veracyte is headquartered in San Francisco, California, the US.

Gain a 360-degree view of Veracyte Inc and make more informed decisions for your business Gain a 360-degree view of Veracyte Inc and make more informed decisions for your business Register your interest
Headquarters United States of America

Address 6000 Shoreline Court, Suite 300, South San Francisco, California, 94080


Telephone 1 650 2436300

No of Employees 755

Industry Medical Equipment

Ticker Symbol & Exchange VCYT (NASD)

Revenue (2024) $517.1M 16% (2024 vs 2023)

EPS XYZ

Net Income (2024) XYZ 174.9% (2024 vs 2023)

Market Cap* $4.6B

Net Profit Margin (2024) XYZ 137.2% (2024 vs 2023)

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Register your interest

Veracyte Inc premium industry data and analytics

120+

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

19+

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Veracyte Inc’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Brands
Afirma Genomic Sequencing Classifier: Thyroid Cancer Percepta
Decipher Prostate Genomic Classifier: Prostate Cancer Prosigna
Decipher Bladder Genomic Classifier: Bladder Cancer Afirma
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Veracyte Inc portfolio and identify potential areas for collaboration Understand Veracyte Inc portfolio and identify potential areas for collaboration Register your interest
Image for loader

Competitor Comparison

Key Parameters Veracyte Inc Exact Sciences Corp Natera Inc Guardant Health Inc Myriad Genetics Inc
Headquarters United States of America United States of America United States of America United States of America United States of America
City South San Francisco Madison Austin Palo Alto Salt Lake
State/Province California Wisconsin Texas California Utah
No. of Employees 755 7,200 6,135 2,490 2,700
Entity Type Public Private Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Register your interest
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Register your interest
Executives
Name Position Board Since Age
Robert S. Epstein, M.D Chairman Executive Board 2015 70
Marc Stapley Director; Chief Executive Officer Executive Board 2021 56
Rebecca Chambers Chief Financial Officer Senior Management 2021 48
Jonathan Wygant Chief Accounting Officer Senior Management 2022 -
Steven French Chief Information Officer Senior Management 2022 -
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Veracyte Inc key executives to enhance your sales strategy Gain insight into Veracyte Inc key executives to enhance your sales strategy Register your interest
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?